Biotoxtech Co., Ltd
Biotoxtech is a company dedicated to providing comprehensive testing and research services in the field of toxicology, pharmacology, and safety assessment. They focus on various types of toxicity tests, including reproductive, developmental, carcinogenic, genotoxic, and safety pharmacology, among others. The company aims to support the development of pharmaceuticals, chemicals, and other products by offering high-quality, reliable testing services to ensure safety and efficacy.
Industries
Nr. of Employees
medium (51-250)
Biotoxtech Co., Ltd
Cheongju, Ch'ungch'ong-bukto, South Korea, Asia
Patents
Pharmaceutical composition comprising hydroquinone derivative for preventing or treating obesity or nonalcoholic steatohepatitis
US-12102612-B2
View Details
Pharmaceutical composition comprising hydroquinone derivative for preventing or treating obesity or nonalcoholic steatohepatitis
US-12102612-B2
View DetailsServices
Contract preclinical testing including general toxicology, reproductive/developmental toxicity, carcinogenicity, genotoxicity, immunotoxicity and safety pharmacology performed under GLP.
Necropsy, tissue processing, slide preparation, special/immuno-staining, pathology reading and clinical pathology analyses (hematology, biochemistry, coagulation, urinalysis).
In vitro and in vivo efficacy models and ADME/PK and biodistribution studies provided via an affiliated bioanalysis subsidiary.
Standard aquatic ecotoxicity assays (algae growth inhibition, Daphnia immobilization, fish acute toxicity) for environmental hazard assessment.
Provide telemetry cardiovascular monitoring, whole-body plethysmography, hERG channel testing and flow cytometry-based immune assays as standalone or integrated study endpoints.
Consulting and study design to meet ICH, OECD and regional regulator requirements and to align preclinical testing with development objectives.
Contract preclinical testing including general toxicology, reproductive/developmental toxicity, carcinogenicity, genotoxicity, immunotoxicity and safety pharmacology performed under GLP.
Necropsy, tissue processing, slide preparation, special/immuno-staining, pathology reading and clinical pathology analyses (hematology, biochemistry, coagulation, urinalysis).
In vitro and in vivo efficacy models and ADME/PK and biodistribution studies provided via an affiliated bioanalysis subsidiary.
Standard aquatic ecotoxicity assays (algae growth inhibition, Daphnia immobilization, fish acute toxicity) for environmental hazard assessment.
Provide telemetry cardiovascular monitoring, whole-body plethysmography, hERG channel testing and flow cytometry-based immune assays as standalone or integrated study endpoints.
Consulting and study design to meet ICH, OECD and regional regulator requirements and to align preclinical testing with development objectives.
Expertise Areas
- Nonclinical safety assessment
- Preclinical toxicology (acute, repeat-dose, juvenile)
- Reproductive and developmental toxicology
- Carcinogenicity and tumorigenicity studies
Key Technologies
- Telemetry cardiovascular monitoring
- Whole-body plethysmography
- Flow cytometry
- In vitro electrophysiology (hERG) assays
News & Updates
Biotoxtech Receives GLP Certification for Safety Pharmacology Tests
Biotoxtech has been officially certified for Good Laboratory Practice (GLP) compliance in safety pharmacology testing, enhancing its credibility and service quality.
Expansion of Carcinogenicity Testing Capabilities
The company has expanded its facilities and expertise to include more advanced carcinogenicity testing methods, aiming to serve international clients.
Participation in International Toxicology Conferences
Biotoxtech representatives actively participate in global toxicology conferences to stay at the forefront of research and technology.
Advances in Reproductive Toxicity Testing
A recent publication highlights the latest methodologies and findings in reproductive toxicity testing, with contributions from Biotoxtech researchers.
The Role of Genotoxicity Testing in Drug Development
An article discusses how genotoxicity assays are critical in the early screening of new pharmaceuticals, with case studies from Biotoxtech.
Global Trends in Carcinogenicity Testing
An overview of international standards and innovations in carcinogenicity testing, featuring insights from Biotoxtech's recent projects.
Biotoxtech Receives GLP Certification for Safety Pharmacology Tests
Biotoxtech has been officially certified for Good Laboratory Practice (GLP) compliance in safety pharmacology testing, enhancing its credibility and service quality.
Expansion of Carcinogenicity Testing Capabilities
The company has expanded its facilities and expertise to include more advanced carcinogenicity testing methods, aiming to serve international clients.
Participation in International Toxicology Conferences
Biotoxtech representatives actively participate in global toxicology conferences to stay at the forefront of research and technology.
Advances in Reproductive Toxicity Testing
A recent publication highlights the latest methodologies and findings in reproductive toxicity testing, with contributions from Biotoxtech researchers.
The Role of Genotoxicity Testing in Drug Development
An article discusses how genotoxicity assays are critical in the early screening of new pharmaceuticals, with case studies from Biotoxtech.
Global Trends in Carcinogenicity Testing
An overview of international standards and innovations in carcinogenicity testing, featuring insights from Biotoxtech's recent projects.